Sage Therapeutic Com (SAGE)
6.00 x 1 7.23 x 1
Post-market by (Cboe BZX)
6.86 -0.51 (-6.92%) 04/04/25 [NASDAQ]
6.00 x 1 7.23 x 1
Post-market 6.72 -0.14 (-2.04%) 18:49 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -400,666 | -541,489 | -532,784 | -457,892 | 606,073 |
| Depreciation Amortization | -5,450 | -4,947 | 6,975 | 17,228 | 3,678 |
| Accounts payable and accrued liabilities | 2,381 | -8,495 | 8,433 | 6,689 | -11,511 |
| Other Working Capital | 84,762 | -67,384 | 5,671 | -18,506 | -39,729 |
| Other Operating Activity | 51,779 | 81,730 | 51,669 | 74,299 | 105,769 |
| Operating Cash Flow | $-267,194 | $-540,585 | $-460,036 | $-378,182 | $664,280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 266,678 | 443,466 | 326,370 | -1,002,076 | 443,029 |
| PPE Investments | N/A | -553 | -937 | -372 | -345 |
| Investing Cash Flow | $266,678 | $442,913 | $325,433 | $-1,002,448 | $442,684 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,183 | 6,930 | 3,113 | 14,719 | 426,762 |
| Other Financing Activity | -520 | -903 | -43 | -1,385 | 0 |
| Financing Cash Flow | $10,663 | $6,027 | $3,070 | $13,334 | $426,762 |
| Beginning Cash Position | 72,324 | 163,969 | 295,502 | 1,662,798 | 129,072 |
| End Cash Position | 82,471 | 72,324 | 163,969 | 295,502 | 1,662,798 |
| Net Cash Flow | $10,147 | $-91,645 | $-131,533 | $-1,367,296 | $1,533,726 |
| Free Cash Flow | |||||
| Operating Cash Flow | -267,194 | -540,585 | -460,036 | -378,182 | 664,280 |
| Capital Expenditure | N/A | -553 | -937 | -372 | -345 |
| Free Cash Flow | -267,194 | -541,138 | -460,973 | -378,554 | 663,935 |